Li Peng

Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial

Zheng Wang, Jia Fan, Shao‐Lai Zhou et al. · The Lancet · 2025 · 37 citations

Medicine, Oncology, Surgery +13

Omitting radiotherapy is safe in breast cancer patients ≥ 70 years old after breast-conserving surgery without axillary lymph node operation

Ying Zhong, Yali Xu, Yidong Zhou et al. · Scientific Reports · 2020 · 22 citations · Full text

Medicine, Oncology, Surgery +16

Discordance in ER, PR, HER2, and Ki-67 Expression Between Primary and Recurrent/Metastatic Lesions in Patients with Primary Early Stage Breast Cancer and the Clinical Significance: Retrospective Analysis of 75 Cases

Li Peng, Zhen Zhang, Dachun Zhao et al. · Pathology & Oncology Research · 2021 · 19 citations · Full text

Medicine, Oncology, Breast Oncology +16

Breast-conserving surgery without axillary lymph node surgery or radiotherapy is safe for HER2-positive and triple negative breast cancer patients over 70 years of age

Ying Zhong, Yali Xu, Yidong Zhou et al. · Breast Cancer Research and Treatment · 2020 · 15 citations

Medicine, Oncology, Surgery +15

Combined ⁶⁸Ga-NOTA-Evans Blue Lymphoscintigraphy and ⁶⁸Ga-NOTA-RM26 PET/CT Evaluation of Sentinel Lymph Node Metastasis in Breast Cancer Patients

Jie Zang, Qingxing Liu, Huimin Sui et al. · Bioconjugate Chemistry · 2019 · 12 citations

Medicine, Nuclear Medicine, Oncology +17